Patent details

EP2854759 Title: DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER

Basic Information

Publication number:
EP2854759
PCT Application Number:
EP2013001461
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137234159
PCT Publication Number:
WO2013174498
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER
French Title of Invention:
FORMES DE DOSAGE COMPRENANT APIXABAN ET UN AGENT DE FORMATION DE MATRICE
German Title of Invention:
DARREICHUNGSFORMEN MIT APIXABAN UND MATRIXFORMER
SPC Number:

Dates

Filing date:
16/05/2013
Grant date:
18/12/2019
EP Publication Date:
08/04/2015
PCT Publication Date:
28/11/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/12/2019
EP B1 Publication Date:
18/12/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/05/2020
Expiration date:
16/05/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/12/2019
 
 

Name:
ratiopharm GmbH
Address:
Graf-Arco-Strasse 3, 89079 Ulm, Germany (DE)

Inventor

1

Name:
LEUTNER, Dirk
Address:
Germany (DE)

2

Name:
MEERGANS, Dominique
Address:
Germany (DE)

Priority

1

Priority Number:
201213479549
Priority Date:
24/05/2012
Priority Country:
United States (US)

2

Priority Number:
12004041
Priority Date:
24/05/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/00; A61K 9/20; A61K 31/437; A61K 47/32; A61K 47/38; A61P 7/02;

Publication

European Patent Bulletin

Issue number:
201951
Publication date:
18/12/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages